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Abstract. Encapsulation of enzymes allows to preserve their biological activities in various 
environmental conditions, such as exposure to elevated temperature or to proteases. This is 
particularly relevant for in-vivo applications, where proteases represent a severe obstacle to 
maintaining the activity of enzymes. One type of drug delivery carriers suitable for enzyme 
encapsulation is polyelectrolyte multilayer capsules, and one of the most popular ways for 
encapsulation is based on hard templating using CaCO3. In this work, we encapsulate an active 
enzyme, ALP (alkaline phosphatase, involved in metabolism and skeletal development) , into 
thermally shrunk polyelectrolyte multilayer (PDADMAC/PSS)4 capsules (average diameter of 
3.56 µm) templated on CaCO3 microparticles and study activity of the encapsulated enzymes. 
At the optimal temperature for encapsulation (42°C), activity of the enzyme is almost four times 
higher than that at 30°C or 50°C. Retention of the enzyme activity has been assessed and the 
evolution of capsule size and density has been monitored in situ using fluorescence and atomic 
force microscopic techniques.  
  




Encapsulation of enzymes is important for biochemistry to enable in-vivo applications. 
Polyelectrolyte multilayer (PEM) capsules represent some of the best suited types of delivery 
vehicles; they are assembled by sequential coating of sacrificial templates with polymeric layers 
and subsequently dissolving of the template leaving an empty polymeric shell (capsule). 
Multifunctionality, versatility and stimuli-responsiveness[1] make PEM capsules unique drug 
delivery carriers. PEM capsules are particularly suited for enzyme encapsulation[2–7] (please 
remove ref. 4) due to the properties of the polymeric shell – i.e. permeability to ions, which are 
used to dissolve the template, as well as to small molecules, which can serve as substrates for 
the enzyme. The capsules can effectively preserve and host rather large organic molecules, such 
as peptides, proteins, and even active enzymes. Such capsules are becoming important drug 
delivery carriers and they have been shown to carry essential functionality in regard with 
preserving the activity of enzymes against proteases.[8]  
Various methods are available for fabrication of PEM microcapsules[9,10] and many of these are 
suitable for encapsulation of enzymes[11] – this application is seen as one of the most extensive 
applications of microcapsules. Another interesting feature of PEM microcapsules is that 
enzymatic reactions can be monitored by fluorescence microscopy,[12] and this can be carried 
out with sensoric functions, which have been recently classified,[13] as was shown for a sensor 
detecting urea.[14] Microcapsules have been designed for use in diverse areas of bio-medical 
applications[15] and sensorics,[16] and elaborate enzymatically controlled reactions have been 
monitored,[17] including those in multicompartment[18] capsules.[19] Both synthetic and 
biodegradable polymers can be employed for constructing the PEM shell of the capsules. The 
polymers can be used for initiating[20] or controlling[21]  the release rate from microcapsules, 
and for preserving enzymes for biological applications.  
Among different encapsulation strategies, heat treatment is a very promising method, because 
the size and mechanical properties of such capsules[22] and planar layers[23,24] can be 
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controlled. In regard with sacrificial particles serving as templates on which polyelectrolyte 
multilayers are deposited, vaterite CaCO3particles are seen as one of the most promising 
candidates due to their bio-friendliness and inexpensiveness. Enzymes can effectively be 
encapsulated into the CaCO3 vaterite particles being loaded at extremely high concentrations 
(tens of mM) keeping their bioactivity which is mainly affected by pH value during enzyme 
loading (10.1016/j.matdes.2019.108223; 10.1016/j.colsurfb.2019.05.077). The co-synthesis is 
nowadays one of the most effective methods to load molecules of various nature including 
proteins, polysaccharides and also small drugs (10.1016/j.matdes.2019.108020; 
10.1016/j.jcis.2019.03.042; 10.1039/c7cp07836f).   Thermal shrinking has been implemented 
on small calcium carbonate particles[26–28]. In addition, the main question expected for thermal 
encapsulation of enzymes -how enzymatic activity will be affected by temperature variation- 
is still unanswered.  
In this work, we have encapsulated an active enzyme, ALP (alkaline phosphatase), into 
thermally shrunk microcapsules templated on CaCO3 particles. In situ fluorescence microscopy 
is used to trace the shrinking process of microcapsules, while Atomic Force Microscope (AFM) 
is used to study them in the pre- and post- shrunk states. Furthermore, enzymatic activity is 
analysed for free (not encapsulated) enzymes and at various temperatures up to 60°C upon 
thermally based encapsulation. The best temperature or thermal “window” for encapsulation 
and preservation of catalytic activity of enzymes is identified to be just above the glass 
transition temperature of polyelectrolyte pair constituting the shell.  
 
Increasing temperature leads to capsule shrinkage 
The schematics of experiments on thermal encapsulation is depicted in Figure 1. In order to 
assess the size of capsule shrinkage over the course of heating the particles, tetramethyl-
rhodamine-iso-thiocyanate (TRITC) linked to bovine serum albumin (BSA) is inserted during 
fabrication of the capsules, thus allowing to precisely determine the capsules diameter using 
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fluorescence microscopy. Initially, the capsules were heated in multiple steps to the (maximum) 
temperature of 60°C. At each of these steps, the diameters of multiple capsules were measured 
(Figure 2A). It looks that BSA is distributed rather homogeneously inside the capsules 
indicating its high loading inside. Such capsules having a very high content of proteins and 
polymers inside may serve as mimics of a biological cell (10.1021/acs.langmuir.8b04328).    
Due to the polydispersity of the capsules, the extent of the diameter change of microcapsules 
was chosen as a measure of their shrinkage. During the heating process the diameter shrinks 
gradually (Figure 2B). When 60°C is reached the capsules have shrunk on average to 70% of 
their original diameter. Moreover, when these capsules were cooled down to 30 degrees, no 
significant difference in volume change was observed (Figure 2C). Since these polymers have 
a glass transition temperature at ~ 40°C, determined by differential scanning calorimetry,[29] 
heating the capsules above this temperature allows reorganisation of polymers accompanied 
with the size reduction of PEM microcapsules. The glass transition temperature depends on the 
polyelectrolyte polymers, water molecules,[30,31] complexation of polymers,[32] and salt ions[33] 
in the solution. Temperature can affect the structure of both as-prepared multilayers and also 
growing ones (10.1039/c6cp00345a).  
AFM also allows morphological characterization. In this case it is interesting to look how 
shrinkage influences the density of capsules after drying. To measure this parameter, the ratio 
of surface area over volume was calculated. An example of the typical morphology of dried 
capsules before and after shrinking is shown in Figure 3A. Data of this experiment revealed 
that for the heated shrunk particles the density of the shell-forming polymers is significantly 
higher (Figure 3B). Therefore, the ratio of area over height is smaller for the heated capsules 
by the factor of six, as it is seen from Figure 3C. It should be noted that silica templated capsules 
appear much flatter[34] in comparison to those templated on calcium carbonate (Figure 3A), 
which is consistent with very different mechanical response of silica[35] templated versus 
calcium carbonate[36] templated capsules 




Temperature dependent shrinkage increases the encapsulation efficiency 
To test how the heat-induced shrinkage process can be used to encapsulate enzyme, an activity 
assay was performed with ALP. To determine the amount of active ALP in the capsules, an 
enzyme activity standard curve for increasing concentrations of ALP was set-up at multiple 
temperatures (Figure S1, Supporting Information). This allowed to analyse the inactivation of 
free ALP at increasing temperatures (Figure 4 A). These data showed (orange bars in Figure 1 
B) a decreasing activity of the enzyme to 67, 33 and 18% upon heating for 1 hour at 40, 50 and 
60°C, respectively. The grey part of the bars in Figure 4 B represent enzymes deactivated by 
the thermal treatment. The degradation rate has a linear dependence on the temperature (R² 
=0.99957), the degradation coefficient is -0.01667 mg/mL active ALP per increased degree. 
These experiments served as a control for monitoring the activity of enzymes encapsulated into 
thermally shrunk microcapsules.  
Subsequently, capsules were heated to the same temperatures in the presence of ALP, which 
was allowed to penetrate inside capsules. The schematics of these experiments showing details 
of this process are depicted in Figure 4 C. After heating, the capsules were centrifuged, and 
ALP activity was assessed in the capsules (Figure 4 E). Interestingly, when looking at the 
percentage of active and encapsulated ALP (Figure 4 E), the values are higher at 40°C and 50°C 
compared to that at 30°C. When combining these data with previously made observation that 
capsules shrink at elevated temperatures (Figure 2), it shows that by shrinking one can 
effectively reach a higher concentration of ALP inside capsules. The most attractive 
temperature (in terms of encapsulation efficiency and enzyme performance) is found to be 42°C 
(Figure 4 E). At this and slightly higher (several degrees) temperatures, a high percentage of 
encapsulated ALP can be achieved. In comparison to activity of enzymes exposed to 30°C or 
encapsulated at 50°C, the activity of enzymes encapsulated at 42°C is found to be 
approximately four times higher (Figure 4 E). As it was mentioned above, 42°C degree 
     
6 
 
represents temperature that lies just above the glass transition temperature (~4 0°C) of the used 
polyelectrolyte pair (PDADMAC/PSS). At temperatures below 40°C, these polyelectrolytes 
assembled in a multilayer are situated still in a “glassy” state, i.e. no encapsulation takes place, 
while at higher temperature (50°C and higher) although activity is higher (yellow curve in 
Figure 4D), the overall activity of all enzymes is decreasing (blue line in Figure 4 D). 
At 30°C almost no shrinkage takes place, as it can be also concluded from previous experiments 
and at 60°C extensive inactivation has occurred. Considering the increased inactivation of ALP 
at higher temperatures, the total active ALP (the encapsulated ALP (AC) is compared (as a ratio) 
to ALP in the supernatant (AS) + encapsulated ALP (AC)). It can be noticed that this value 
(Ac/Ac+As) increased from 30°C to 40°C and remains constant at 50°C. This indicates a 
possibility that encapsulation protects the enzyme against temperature induced inactivation. 
Conclusion 
In conclusion, active enzymes alkaline phosphatase (ALP) have been encapsulated into 
thermally shrunk polyelectrolyte multilayer capsules templated on CaCO3 microparticles. In 
situ monitoring of capsule shrinking has been conducted by a confocal laser scanning 
microscope, while AFM was used to study profiles of capsules with encapsulated enzymes. 
Substantially thicker (almost two times comparing the maximum height) capsules, have been 
obtained after shrinkage. An important application of polyelectrolyte multilayer capsules, 
enzyme encapsulation was carried out yielding a novel procedure for heat-processing of 
enzymes, which maintained their activity upon encapsulation. Optimal temperature has been 
found for encapsulation of enzymes (42°C), and it is situated just above the glass transition 
temperature of ~ 40°C of the used polyelectrolyte pair (PDADMAC/PSS). Enzyme activity in 
capsules shrunk at the optimal temperature is approximately four times higher than that 
measured upon exposure to 30°C or upon encapsulation at 50°C. An important application of 
polyelectrolyte multilayer capsules, i.e. enzyme encapsulation, was proven yielding a novel 
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procedure for temperature-based encapsulation of enzymes keeping their catalytic bioactivity 
to a high value. 
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Experimental Section  
Fabrication of capsules. Multilayer capsules were synthesized by sequential absorption of 
electrostatically interacting oppositely charged polymer pair (PDADMAC/PSS). In detail, 
excess of 2 mg/mL positively charged polymer solution in 0.5 M NaCl was added to templates, 
CaCO3 particles, which were fabricated by the method reported previously 
(10.1039/c7cp07836f)) (briefly, 0.3 M of sodium carbonate is added to 0.3 M of calcium 
chloride upon a rigorous stirring. Subsequently, the particles are collected from the solution and 
cleaned with water by centrifugation). The mixture was treated with ultrasound for 10 seconds, 
then incubated for 10 minutes. Then, it was washed three times with water. Subsequently, the 
second layer was constructed using the negatively charged polymer solution. The above process 
was repeated 4 times to generate PEM capsules of (PDADMAC/PSS)4. 
Ethylenediaminetetraacetic acid (EDTA) solutions was used to remove the sacrificial CaCO3 
core to obtain the hollow capsules. 
Fluorescence microscopy investigation of the volume shrinkage. To assess the volume 
shrinkage by temperature increase, capsules were imaged using fluorescence microscopy. 
Images were made on a Nikon TE2000 (automated inverted microscope) using a sensitive 
digital sCMOS camera (Hamamatsu Orca-fusion C14440-2UP). The inclusion of TRITC 
polymer in the shell of the capsule allows to precisely measure the diameter of the particles at 
increasing temperatures. This diameter is used in turn to calculate the volume changes of the 
capsule. 
AFM experiments. In order to visualise the capsules before and after shrinking with AFM, the 
capsules were air dried on a coverslip. The nanowizard 4™ (JPK bioAFM, Bruker) was used 
to obtain images of the samples in air, using QI-mode©. The probe used in these imaging 
measurements is the AIO (Budgetsensors), on this chip a cantilever with a spring constant of 
7.4 N/m was used, this cantilever has a tip radius of <10 nm. Image processing and roughness 
calculation was performed in the software provided by the manufacturer (JPK data processing 
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software). In order to determine the capsule density, the 2D area of the capsules weight divided 
it by the maximum height per capsules (10 per condition). The ratio of area over height gives 
an approximation of the density. 
Enzyme activity measurements. Enzyme activity of ALP was measured by a colorimetric 
reaction between ALP and the substrate p-NPP (p-nitrophenylphosphate). The speed of this 
reaction can be assessed with a spectrophotometer by measuring the absorbance change at 405 
nm in a plate reader (Tecan, Infinite 200Pro). To correlate the speed of reaction to the amount 
of ALP in the sample, a standard curve was established using multiple concentrations of ALP 
assessed together with 5 mM of ALP substrate (p-NPP) in a 0.5 M solution of ALP buffer. The 
same reaction solution was used to determine the temperature stability of ALP and activity of 
the encapsulated ALP. Encapsulation of ALP was performed by combining a 100 µL of a 1 
mg/mL ALP solution with 100 µL of capsules (containing approximately 30E+06 capsules). 
These two solutions were subsequently incubated during one hour at the predetermined 
temperature. After this hour the ALP/capsule mixtures were centrifuged twice and the enzyme 
activity was measured in both the supernatant as in the capsule fraction, in order to determine 
the amount of encapsulated active ALP. 
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Figure 1. Schematics depicting the course of experiments: an enzyme (ALP) has been 
encapsulated by a thermally shrunk process (A); in situ investigation of enzyme activity of 
microcapsules (B). The thermal shrinking process of capsules is characterized by: (C) a 
confocal scanning laser microscope (in situ size reduction); and (D) AFM (atomic force 
microscope) revealing the thickness of capsules before and after shrinking.  
 
  




Figure 2. Decrease of the size of capsules upon heat-shrinking. The procedure was monitored 
in situ using a confocal laser scanning microscope (A). Monitoring of the diameter decrease of 
capsules upon shrinking (B).  
 
  





Figure 3. (A) Monitoring of the volume change of capsules upon cooling down to 30 degrees. 
(B) Height profiles as imaged by AFM in the panel (A). (C) The ratio of the area to height for 
pre-shrunk and post-shrunk capsules.  
 
  





Figure 4. (A) Schematic of the control experiment of deactivating ALP (grey dots) shown 
together with active ALP (orange dots) upon exposure to elevated temperatures. (B)  Reduction 
of the active free ALP (no encapsulation) after exposing to elevated temperatures (the initial 
ALP concentration is 0.5 mg/mL). (C) Schematics of encapsulation of ALP into capsules upon 
exposure to elevated temperatures. (D) Comparison of the total active ALP (blue) (AS= activity 
ALP in supernatant, AC= activity encapsulated ALP, AI = initial activity of ALP) to the 
percentage of active ALP present inside the capsules, after heating (orange). (E) Concentration 
of active ALP that is encapsulated due to shrinkage of the capsules. (*indicates that the value 
was lower than the detection limit in the calibration curve i.e. 0.0001 mg/mL). The window for 
thermal encapsulation is shown in the background in green color with a gradient.  
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Figure S1: The calibration curve correlating the concentration of ALP with the increase of 
absorbance over time during the enzymatic reactions. Different colours indicate the multiple 
temperatures, at which calibration curves were calculated.  




Figure S2: Bar graph which indicates the concentration of active ALP measured inside the 
particles, error bars indicate the standard deviation. 
